The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Bristol-Myers Squibb; Merck KGaA; MSD
Consulting or Advisory Role - Bristol-Myers Squibb; Merck KGaA
Travel, Accommodations, Expenses - Merck KGaA
Long-term follow-up of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in advanced squamous cell carcinoma of the head and neck (SCCHN).
 
Byoung Chul Cho
Leadership - Gencurix; Interpark Bio
Stock and Other Ownership Interests - Bridgebio; Cyrus Therapeutics; Gencurix; Interpark Bio; Kanaph Therapeutics; Theravance
Consulting or Advisory Role - AstraZeneca; Blueprint medicines; Boehringer Ingelheim; Bridgebio; Bristol-Myers Squibb; Cyrus Therapeutics; Guardant Health; Janssen; Kanaph Therapeutics; Lilly; Medpacto; MSD; Novartis; Ono Pharmaceutical; Oscotec; Pfizer; Roche; Takeda; Yuhan
Research Funding - Abbvie; AstraZeneca; Bayer; Blueprint medicines; Champions Oncology; Dizal Pharma; Dong-A ST; GI Innovation; Interpark Bio; Janssen; Lilly; Medpacto; Mogam Biotechnology Research Institue; MSD; Novartis; Ono Pharmaceutical; Yuhan
Patents, Royalties, Other Intellectual Property - Champions Oncology
Other Relationship - DAAN Biotherapeutics
 
Amaury Daste
No Relationships to Disclose
 
Alain Ravaud
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Ipsen; Merck KGaA; MSD Oncology; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Merck KGaA (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; ipsen; MSD; Novartis; Pfizer; Roche
 
Sébastien Salas
No Relationships to Disclose
 
Nicolas Isambert
Consulting or Advisory Role - Daichii; Ipsen; Pfizer; Transgene
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar
 
Edward Francis McClay
Speakers' Bureau - Bristol-Myers Squibb; Merck KGaA
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA
 
Ahmad Awada
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Eisai; Genomic Health; Ipsen; LEO Pharma; Lilly; Merck Serono; MSD; Novartis; Pfizer; Roche
 
Christian Borel
No Relationships to Disclose
 
Christoph Helwig
Employment - Merck
Stock and Other Ownership Interests - Merck
 
P. Alexander Rolfe
Employment - EMD Serono; EMD Serono
 
Laureen S. Ojalvo
Employment - EMD Serono
Patents, Royalties, Other Intellectual Property - EMD Serono
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); ImmunityBio (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst)
 
Nicolas Penel
Research Funding - Bayer (Inst); Bayer (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; Astellas Pharma; Janssen-Cilag
Other Relationship - PharmaMar